Actively Recruiting
Rare Tumours in Children and Adolescents (STEP)
Led by University Hospital Tuebingen · Updated on 2024-10-01
10000
Participants Needed
1
Research Sites
1668 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the STEP registry is to collect and evaluate experience and data on the diagnosis and treatment of rare childhood tumors in order to use the knowledge gained to improve the treatment prospects for our patients. The rarity of a disease should not be a disadvantage for the young patients.
CONDITIONS
Official Title
Rare Tumours in Children and Adolescents (STEP)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of a rare solid tumor
- Age at diagnosis from neonatal period to 18 years
- Information, education, and written consent provided by patient or guardian
- Not currently enrolled in any clinical studies or registries of the German Society for Pediatric Oncology and Hematology (GPOH)
You will not qualify if you...
- Tumor diagnosis already registered in a prospective therapy study or another clinical registry of the GPOH
- Lack of information, explanation, or written consent from the patient or legal guardian
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Tübingen
Tübingen, Germany, 72076
Actively Recruiting
Research Team
I
Ines Brecht, PD Dr. med.
CONTACT
M
Michael Abele, Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here